×
About 1,163 results

ALLMedicine™ Myopathy Center

Research & Reviews  445 results

Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case rep...
https://doi.org/10.1007/s12350-022-02990-x 10.1186/1750-1172-8-31 10.1007/s00508-020-01781-z 10.1001/archneur.62.7.1057 10.7861/clinmedicine.18-2-s30 10.3949/ccjm.84.s3.02 10.1002/mus.26723 10.1093/ehjci/jeu107 10.3109/13506129.2014.967846 10.3109/13506129.2011.615872 10.1007/s12350-017-1166-7
Journal of Nuclear Cardiology : Official Publication of T... Ungericht M, Wanschitz J et. al.

May 18th, 2022 - We identified two patients with transthyretin (ATTR) amyloid myopathy (one ATTR variant amyloidosis, ATTRv; one wild-type ATTR amyloidosis, ATTRwt). Myopathy was the initial manifestation in ATTRwt, whereas it followed neuropathy and cardiomyopath...

Coexisting sporadic late onset nemaline myopathy and AL amyloid myopathy - incidental o...
https://doi.org/10.1016/j.nmd.2022.03.006
Neuromuscular Disorders : NMD; Moshe-Lilie O, Banks G et. al.

May 14th, 2022 - Sporadic late onset nemaline myopathy (SLONM) and amyloid myopathy are frequently unrecognized acquired and treatable myopathies, which classically present with rapidly progressive and severe proximal muscle weakness. We report a case of SLONM and...

Neuromuscular complications of severe COVID-19 in paediatric patients: Medium-term foll...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993496
Neuromuscular Disorders : NMD; Avila-Smirnow D, Céspedes P et. al.

May 14th, 2022 - Neuromuscular complications in paediatric patients with severe coronavirus disease 2019 (COVID-19) are poorly characterised. However, adult patients with severe COVID-19 reportedly present with frequent neuromuscular complications that mainly incl...

Atrial mitral regurgitation: Characteristics and outcomes of transcatheter mitral valve...
https://doi.org/10.1002/ccd.30224
Catheterization and Cardiovascular Interventions : Offici... Simard T, Reddy YNV et. al.

May 11th, 2022 - Mitral transcatheter edge-to-edge repair (MTEER) is an established therapeutic approach for mitral regurgitation (MR). Functional mitral regurgitation originating from atrial myopathy (A-FMR) has been described. We sought to assess the clinical, e...

Clinical and pathological features of immune-mediated necrotising myopathies in a singl...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074315
BMC Musculoskeletal Disorders; Yang H, Tian X et. al.

May 7th, 2022 - Immune-mediated necrotising myopathy (IMNM) is a subset of idiopathic inflammatory myopathies (IIM) characterized by significantly elevated creatine kinase level, muscle weakness and predominant muscle fibre necrosis in muscle biopsy. This study a...

see more →

Drugs  15 results see all →

News  4 results

Stealth Bio's neuromuscular disorder drug fails trial; shares plummet
https://www.reuters.com/article/us-stealth-biothera-study/stealth-bios-neuromuscular-disorder-drug-fails-trial-shares-plummet-idUSKBN1YO1JG

Dec 20th, 2019 - (Reuters) - Stealth BioTherapeutics Corp’s shares crashed on Friday after its lead neuromuscular disorder drug candidate failed to help patients walk better and reduce fatigue, a major setback to the company’s wide mitochondrial diseases pipeline....

HPS2-THRIVE: High Myopathy Risk With Niacin/Laropiprant
https://www.medscape.com/viewarticle/779957

Feb 27th, 2013 - (Updated) OXFORD, UK — New data shed some light on the adverse events associated with extended-release niacin and the antiflushing agent laropiprant in the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-...

HPS2-THRIVE: High Myopathy Risk With Niacin/Laropiprant
https://www.staging.medscape.com/viewarticle/779957

Feb 27th, 2013 - (Updated) OXFORD, UK — New data shed some light on the adverse events associated with extended-release niacin and the antiflushing agent laropiprant in the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-...

Statin Induced Myopathy
https://www.medscape.com/viewarticle/802770

Jul 29th, 2008 - This feature requires the newest version of Flash. You can download it here. Discussion of an important discovery published in NEJM. What are your thoughts on the implications for clinical practice?    See these articles: SLCO1B1 Variants and Stat...

see more →

Patient Education  1 results see all →